directory

Convergent Therapeutics, Inc. | Company Profile

Company Directory for Convergent Therapeutics, Inc.

Team Bitscale

— 1 min read

Convergent Therapeutics, Inc.

Overview

Convergent Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2021. The company focuses on developing next-generation targeted radiotherapies, particularly alpha radioantibodies, aimed at treating prostate cancer and other cancers. Their proprietary dual-targeted radionuclide therapies utilize monoclonal antibodies conjugated with alpha-emitting isotopes, such as actinium-225, to effectively target cancer cells while minimizing harm to healthy tissues.

The lead product candidate, CONV01-α, targets prostate-specific membrane antigen (PSMA) and is designed for PSMA-positive castration-resistant prostate cancer. It has shown promising results in Phase 1/2 trials and has received FDA clearance for its IND application, with Phase 2 trials set to begin in 2024. Another candidate, In-111 rosopatamab tetraxetan, is also in Phase 2 development for the same indication. The company employs innovative radioantibody technology to enhance the precision of radiation therapy, focusing on improving treatment outcomes for cancer patients.

Basic Information

Industry research
Founded 2021
Revenue 92M
Headquarters 1 Broadway, Cambridge, Massachusetts, United States, 02142

Contact Details

Key Focus Areas & Initiatives

  • Biotechnology research
  • Pharmaceuticals
  • Short-range radiation
  • Radiopharmaceutical development
  • Research and development in the physical, engineering, and life sciences
  • Actinium-225
  • Radiopharmaceuticals
  • Targeted alpha therapy
  • Radioisotope conjugates
  • Radioligand therapy
  • Healthcare
  • Cancer biomarkers
  • DNA damage induction
  • Alpha emitters
  • PSMA-targeted therapy
  • PSMA antibodies
  • PSMA targeting
  • Monoclonal antibodies
  • Alpha-emitting payloads
  • Metastatic castration-resistant prostate cancer
  • Alpha radiation
  • Next-generation radiotherapy
  • Targeted radiotherapies
  • Clinical development
  • Alpha particle therapy
  • CONV01-α
  • Cancer targeting
  • Radioantibodies
  • Prostate cancer
  • Radioantibody platform
  • Precision radiotherapy
  • Targeted cancer therapy
  • Precision oncology
  • Radiotherapy
  • Oncology therapeutics
  • Cancer treatment
  • Clinical trials
  • Cancer cell targeting
  • Metastatic cancer
  • Biotech innovation
  • Clinical trial updates
  • Medical
  • Health care
  • Health, wellness & fitness
  • Hospital & health care

Technologies Used

  • Google Tag Manager
  • IoT
  • Mobile Friendly
  • Outlook
  • Remote
  • Typekit
  • WordPress.org

Read more